{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:11:13Z","timestamp":1788459073771,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We optimized the protocol for thyroid ablation in living mice using radioactive iodine (RAI) and a low-iodine diet (LID). To examine the effect of LID on thyroid ablation, mice were randomly divided into 4 groups: Vehicle, <jats:sup>131<\/jats:sup>I 2.775 MBq, <jats:sup>131<\/jats:sup>I 5.55 MBq, and LID\u2009+\u2009<jats:sup>131<\/jats:sup>I 2.775 MBq. The LID group was fed a LID for up to 7 days and then mice in the <jats:sup>131<\/jats:sup>I 2.775, <jats:sup>131<\/jats:sup>I 5.55, and LID\u2009+\u2009<jats:sup>131<\/jats:sup>I 2.775 MBq groups were intravenously administrated with <jats:sup>131<\/jats:sup>I, respectively. Scintigraphy imaging with <jats:sup>99m<\/jats:sup>Tc pertechnetate was performed once in 2 weeks for 4 weeks. After establishment of athyroid mice, control or athyroid mice were injected with human anaplastic thyroid cancer cells co-expressing sodium iodine symporter and enhanced firefly luciferase (ARO\/NF) to evaluate RAI uptake. Scintigraphy imaging with <jats:sup>99m<\/jats:sup>Tc pertechnetate was performed with ARO\/NF tumor-bearing mice. Scintigraphy imaging showed decreased thyroid uptake in the LID\u2009+\u2009<jats:sup>131<\/jats:sup>I 2.775 MBq group compared to other groups. Scintigraphy images showed that tumor uptake was statically higher in athyroid mice than in control mice. These data suggest that these optimized conditions for thyroid ablation could be helpful to establish an <jats:italic>in vivo<\/jats:italic> mouse model.<\/jats:p>","DOI":"10.1038\/s41598-017-13772-8","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T14:21:19Z","timestamp":1507645279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of an athyroid mouse model using 131I ablation after preparation with a low-iodine diet"],"prefix":"10.1038","volume":"7","author":[{"given":"Ji Min","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilkumar","family":"Kalimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-4604","authenticated-orcid":false,"given":"Prakash","family":"Gangadaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hwan","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-6982","authenticated-orcid":false,"given":"Chae Moon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaetae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Cheol","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"13772_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics. CA. Cancer J. Clin. \n                           65, 5\u201329 (2015).","journal-title":"CA. Cancer J. Clin."},{"key":"13772_CR2","first-page":"869","volume":"17","author":"A Milano","year":"2006","unstructured":"Milano, A. et al. New molecular targeted therapies in thyroid cancer: Anticancer. Drugs \n                           17, 869\u2013879 (2006).","journal-title":"New molecular targeted therapies in thyroid cancer: Anticancer. Drugs"},{"key":"13772_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1590\/S0004-27302009000900002","volume":"53","author":"S Romagnoli","year":"2009","unstructured":"Romagnoli, S., Moretti, S., Voce, P. & Puxeddu, E. Targeted molecular therapies in thyroid carcinoma. Arq. Bras. Endocrinol. Amp Metabol. \n                           53, 1061\u20131073 (2009).","journal-title":"Arq. Bras. Endocrinol. Amp Metabol."},{"key":"13772_CR4","volume":"2013","author":"G Pellegriti","year":"2013","unstructured":"Pellegriti, G. et al. Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors, Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors. J. Cancer Epidemiol. J. Cancer Epidemiol. \n                           2013, e965212 (2013).","journal-title":"J. Cancer Epidemiol. J. Cancer Epidemiol."},{"key":"13772_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.14310\/horm.2002.1260","volume":"9","author":"L Wartofsky","year":"2010","unstructured":"Wartofsky, L. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Horm. Athens Greece \n                           9, 103\u2013108 (2010).","journal-title":"Horm. Athens Greece"},{"key":"13772_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1210\/jc.2012-3682","volume":"98","author":"W Cheng","year":"2013","unstructured":"Cheng, W. et al. Low- or High-Dose Radioiodine Remnant Ablation for Differentiated Thyroid Carcinoma: A Meta-Analysis. J. Clin. Endocrinol. Metab. \n                           98, 1353\u20131360 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"13772_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/eje.1.02014","volume":"153","author":"F Pacini","year":"2005","unstructured":"Pacini, F. et al. Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur. J. Endocrinol. \n                           153, 651\u2013659 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"13772_CR8","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2574::AID-CNCR22>3.0.CO;2-O","volume":"77","author":"C Bal","year":"1996","unstructured":"Bal, C., Padhy, A. K., Jana, S., Pant, G. S. & Basu, A. K. Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer \n                           77, 2574\u20132580 (1996).","journal-title":"Cancer"},{"key":"13772_CR9","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/annonc\/mdp050","volume":"20","author":"R Sciuto","year":"2009","unstructured":"Sciuto, R. et al. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann. Oncol. \n                           20, 1728\u20131735 (2009).","journal-title":"Ann. Oncol."},{"key":"13772_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.mcna.2012.01.002","volume":"96","author":"F Pacini","year":"2012","unstructured":"Pacini, F. & Castagna, M. G. Approach to and Treatment of Differentiated Thyroid Carcinoma. Med. Clin. North Am. \n                           96, 369\u2013383 (2012).","journal-title":"Med. Clin. North Am."},{"key":"13772_CR11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(13)60109-9","volume":"381","author":"M Xing","year":"2013","unstructured":"Xing, M., Haugen, B. R. & Schlumberger, M. Progress in molecular-based management of differentiated thyroid cancer. Lancet \n                           381, 1058\u20131069 (2013).","journal-title":"Lancet"},{"key":"13772_CR12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/RLU.0000000000000324","volume":"39","author":"A Amin","year":"2014","unstructured":"Amin, A., Badwey, A. & El-Fatah, S. Differentiated thyroid carcinoma: an analysis of 249 patients undergoing therapy and aftercare at a single institution. Clin. Nucl. Med. \n                           39, 142\u2013146 (2014).","journal-title":"Clin. Nucl. Med."},{"key":"13772_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/08941930591004485","volume":"18","author":"MK Sakurai","year":"2005","unstructured":"Sakurai, M. K., Greene, A. K., Wilson, J., Fauza, D. & Puder, M. Pneumonectomy in the Mouse: Technique and Perioperative Management. J. Invest. Surg. \n                           18, 201\u2013205 (2005).","journal-title":"J. Invest. Surg."},{"key":"13772_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4103\/2230-8210.109671","volume":"17","author":"SJS Bajwa","year":"2013","unstructured":"Bajwa, S. J. S. & Sehgal, V. Anesthesia and thyroid surgery: The never ending challenges. Indian J. Endocrinol. Metab. \n                           17, 228\u2013234 (2013).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"13772_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0002-9610(98)00099-3","volume":"176","author":"R Bergamaschi","year":"1998","unstructured":"Bergamaschi, R., Becouarn, G., Ronceray, J. & Arnaud, J.-P. Morbidity of thyroid surgery. Am. J. Surg. \n                           176, 71\u201375 (1998).","journal-title":"Am. J. Surg."},{"key":"13772_CR16","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","volume":"86","author":"EL Mazzaferri","year":"2001","unstructured":"Mazzaferri, E. L. & Kloos, R. T. Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer. J. Clin. Endocrinol. Metab. \n                           86, 1447\u20131463 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"13772_CR17","first-page":"1132","volume":"33","author":"HR Maxon","year":"1992","unstructured":"Maxon, H. R. et al. Radioiodine-131 Therapy for Well-Differentiated Thyroid Cancer\u2014A Quantitative Radiation Dosimetric Approach: Outcome and Validation in 85 Patients. J. Nucl. Med. \n                           33, 1132\u20131136 (1992).","journal-title":"J. Nucl. Med."},{"key":"13772_CR18","first-page":"131","volume":"40","author":"EE Furhang","year":"1999","unstructured":"Furhang, E. E., Larson, S. M., Buranapong, P. & Humm, J. L. Thyroid Cancer Dosimetry Using Clearance Fitting. J. Nucl. Med. \n                           40, 131\u2013136 (1999).","journal-title":"J. Nucl. Med."},{"key":"13772_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/00006231-200305000-00002","volume":"24","author":"M Karam","year":"2003","unstructured":"Karam, M. et al. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Nucl. Med. Commun. \n                           24, 489\u2013495 (2003).","journal-title":"Nucl. Med. Commun."},{"key":"13772_CR20","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJM198310203091601","volume":"309","author":"HR Maxon","year":"1983","unstructured":"Maxon, H. R. et al. Relation between Effective Radiation Dose and Outcome of Radioiodine Therapy for Thyroid Cancer. N. Engl. J. Med. \n                           309, 937\u2013941 (1983).","journal-title":"N. Engl. J. Med."},{"key":"13772_CR21","first-page":"277","volume":"14","author":"Y Kasuga","year":"1991","unstructured":"Kasuga, Y. et al. The effect of xenotransplantation of human thyroid tissue following radioactive iodine-induced thyroid ablation on thyroid function in the nude mouse. Clin. Investig. Med. M\u00e9decine Clin. Exp. \n                           14, 277\u2013281 (1991).","journal-title":"Clin. Investig. Med. M\u00e9decine Clin. Exp."},{"key":"13772_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1172\/JCI6397","volume":"104","author":"ED Abel","year":"1999","unstructured":"Abel, E. D. et al. Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system. J. Clin. Invest. \n                           104, 291\u2013300 (1999).","journal-title":"J. Clin. Invest."},{"key":"13772_CR23","doi-asserted-by":"publisher","first-page":"E1321","DOI":"10.1073\/pnas.1109926108","volume":"108","author":"O Barca-Mayo","year":"2011","unstructured":"Barca-Mayo, O. et al. Role of type 2 deiodinase in response to acute lung injury (ALI) in mice. Proc. Natl. Acad. Sci. USA \n                           108, E1321\u20131329 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"13772_CR24","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-66-16040P","volume":"66","author":"A Gorbman","year":"1947","unstructured":"Gorbman, A. Effects of radiotoxic dosages of I131 upon thyroid and contiguous tissues in mice. Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N \n                           66, 212 (1947).","journal-title":"Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N"},{"key":"13772_CR25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1210\/jcem-10-10-1177","volume":"10","author":"A Gorbman","year":"1950","unstructured":"Gorbman, A. Functional and structural changes consequent to high dosages of radioactive iodine. J. Clin. Endocrinol. Metab. \n                           10, 1177\u20131191 (1950).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"13772_CR26","first-page":"447","volume":"11","author":"HA Sloviter","year":"1951","unstructured":"Sloviter, H. A. The Effect of Complete Ablation of Thyroid Tissue by Radioactive Iodine on the Survival of Tumor-bearing Mice. Cancer Res. \n                           11, 447\u2013449 (1951).","journal-title":"Cancer Res."},{"key":"13772_CR27","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1089\/thy.2013.0695","volume":"24","author":"M Lee","year":"2014","unstructured":"Lee, M. et al. Low iodine diet for one week is sufficient for adequate preparation of high dose radioactive iodine ablation therapy of differentiated thyroid cancer patients in iodine-rich areas. Thyroid Off. J. Am. Thyroid Assoc. \n                           24, 1289\u20131296 (2014).","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"13772_CR28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1089\/thy.2010.0055","volume":"20","author":"AM Sawka","year":"2010","unstructured":"Sawka, A. M. et al. Dietary Iodine Restriction in Preparation for Radioactive Iodine Treatment or Scanning in Well-Differentiated Thyroid Cancer: A Systematic Review. Thyroid \n                           20, 1129\u20131138 (2010).","journal-title":"Thyroid"},{"key":"13772_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/thy.2012.0136","volume":"23","author":"SY Sohn","year":"2013","unstructured":"Sohn, S. Y. et al. Association Between Excessive Urinary Iodine Excretion and Failure of Radioactive Iodine Thyroid Ablation in Patients with Papillary Thyroid Cancer. Thyroid \n                           23, 741\u2013747 (2013).","journal-title":"Thyroid"},{"key":"13772_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13139-011-0111-y","volume":"46","author":"ID Yoo","year":"2012","unstructured":"Yoo, I. D. et al. The Success Rate of Initial 131I Ablation in Differentiated ThyroidCancer: Comparison Between Less Strict and Very Strict Low Iodine Diets. Nucl. Med. Mol. Imaging \n                           46, 34\u201340 (2012).","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"13772_CR31","doi-asserted-by":"crossref","unstructured":"American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid Off. J. Am. Thyroid Assoc. 19, 1167\u20131214 (2009).","DOI":"10.1089\/thy.2009.0110"},{"key":"13772_CR32","first-page":"1","volume":"23","author":"A Fard-Esfahani","year":"2014","unstructured":"Fard-Esfahani, A. et al. Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease. Iran. J. Nucl. Med. \n                           23, 1\u20137 (2014).","journal-title":"Iran. J. Nucl. Med."},{"key":"13772_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000381019","volume":"4","author":"KA Schmohl","year":"2015","unstructured":"Schmohl, K. A. et al. Establishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice. Eur. Thyroid J. \n                           4, 74\u201380 (2015).","journal-title":"Eur. Thyroid J."},{"key":"13772_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/thy.2012.0106","volume":"23","author":"SY Jeong","year":"2013","unstructured":"Jeong, S. Y., Kim, H. W., Lee, S.-W., Ahn, B.-C. & Lee, J. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid Off. J. Am. Thyroid Assoc. \n                           23, 609\u2013616 (2013).","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"13772_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. \n                           11, 723\u2013737 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"13772_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-500X.72350","volume":"1","author":"S Parasuraman","year":"2010","unstructured":"Parasuraman, S., Raveendran, R. & Kesavan, R. Blood sample collection in small laboratory animals. J. Pharmacol. Pharmacother. \n                           1, 87\u201393 (2010).","journal-title":"J. Pharmacol. Pharmacother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13772-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13772-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13772-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:01:03Z","timestamp":1671796863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13772-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13772"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13772-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]},"assertion":[{"value":"12 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13284"}}